{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:26:03Z","timestamp":1791419163439,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.it.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T05:20:33Z","timestamp":1758950433000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Balancing IL-17\u2013mediated protection and IFN-\u03b3\u2013driven pathology at mucocutaneous barriers"],"prefix":"10.1016","volume":"47","author":[{"given":"Lucas","family":"dos Santos Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-9500","authenticated-orcid":false,"given":"Michail S.","family":"Lionakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.09.002_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0015","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI40891","article-title":"IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice","volume":"120","author":"Cho","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.09.002_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20141065","article-title":"Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis","volume":"212","author":"Ling","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.09.002_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.09.002_bb0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2016.07.016","article-title":"Dedicator of cytokinesis 8-deficient CD4+ T cells are biased to a TH2 effector fate at the expense of TH1 and TH17 cells","volume":"139","author":"Tangye","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","article-title":"Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations","volume":"349","author":"Okada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax7965","article-title":"Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-beta","volume":"4","author":"Li","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq5204","article-title":"Human IL-23 is essential for IFN-gamma-dependent immunity to mycobacteria","volume":"8","author":"Philippot","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.coi.2021.07.011","article-title":"Infections in the monogenic autoimmune syndrome APECED","volume":"72","author":"Oikonomou","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0075","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0080","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.20130877","article-title":"Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections","volume":"211","author":"Conti","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/mi.2012.128","article-title":"Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections","volume":"6","author":"Hernandez-Santos","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007069","article-title":"Langerin+ DCs regulate innate IL-17 production in the oral mucosa during Candida albicans-mediated infection","volume":"14","author":"Sparber","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.09.002_bb0100","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2202348","article-title":"Reappraisal of idiopathic CD4 lymphocytopenia at 30 years","volume":"388","author":"Lisco","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231044","article-title":"Helper T cell immunity in humans with inherited CD4 deficiency","volume":"221","author":"Guerin","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0797","article-title":"A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans","volume":"10","author":"Dutzan","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2016","article-title":"Interferon-gamma and infectious diseases: lessons and prospects","volume":"384","author":"Casanova","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5731","article-title":"Aberrant type 1 immunity drives susceptibility to mucosal fungal infections","volume":"371","author":"Break","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2025.09.002_bb0145","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0150","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-gamma in autoimmune polyendocrine syndrome type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2025.09.002_bb0160","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/jc.2017-00139","article-title":"Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1","volume":"102","author":"Orlova","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.it.2025.09.002_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/08916934.2017.1344972","article-title":"Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I","volume":"50","author":"Oftedal","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.it.2025.09.002_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10875-023-01629-x","article-title":"Ruxolitinib rescues multiorgan clinical autoimmunity in patients with APS-1","volume":"44","author":"Levy","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0185","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jaci.2025.03.026","article-title":"Selective JAK1 inhibition remits multiorgan autoimmunity in a patient with refractory autoimmune polyendocrine syndrome type 1","volume":"155","author":"Hadjiyannis","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0190","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0195","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.immuni.2010.03.001","article-title":"Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways","volume":"32","author":"Nava","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.09.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads2675","article-title":"Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids","volume":"11","author":"Pontejo","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.it.2025.09.002_bb0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","article-title":"Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome","volume":"40","author":"Kong","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0210","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.09.002_bb0215","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2018.11.033","article-title":"STAT1 gain-of-function compromises skin host defense in the context of IFN-gamma signaling","volume":"143","author":"Niehues","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0220","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.09.002_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.70962\/CIS2025abstract.113","article-title":"Thymoma-associated autoimmunity is Th1 driven and can be ameliorated with baricitinib [abstract]","volume":"1","author":"Hetem\u00e4ki","year":"2025","journal-title":"J. Hum. Immun."},{"key":"10.1016\/j.it.2025.09.002_bb0230","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1601-0825.2012.01955.x","article-title":"Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease","volume":"18","author":"Resende","year":"2012","journal-title":"Oral Dis."},{"key":"10.1016\/j.it.2025.09.002_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071722","article-title":"Efficacy and safety of atezolizumab and bevacizumab in the real-world treatment of advanced hepatocellular carcinoma: experience from four tertiary centers","volume":"14","author":"Himmelsbach","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.it.2025.09.002_bb0240","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1128\/AAC.00250-08","article-title":"Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy","volume":"52","author":"Schulbin","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.it.2025.09.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa047","article-title":"Oral cytokine levels are more linked to levels of plasma and oral HIV-1 RNA than to CD4+ T-cell counts in people with HIV","volume":"7","author":"Rocco","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.it.2025.09.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013114","article-title":"The emerging fungal pathogen Candida auris induces IFNgamma to colonize the skin","volume":"21","author":"Das","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.09.002_bb0255","article-title":"The emerging fungal pathogen Candida auris induces IFNgamma to colonize mammalian hair follicles [preprint]","author":"Merrill","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.it.2025.09.002_bb0260","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1056\/NEJMra2402635","article-title":"Candida auris infections","volume":"391","author":"Lionakis","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0265","article-title":"Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies","author":"Huang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.09.002_bb0270","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230558","article-title":"Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis","volume":"220","author":"Singh","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0275","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.09.002_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"Barber","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0295","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105347","article-title":"Damping excessive viral-induced IFN-gamma rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis","volume":"108","author":"Seldeslachts","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.it.2025.09.002_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07866-3","article-title":"Tuberculosis in otherwise healthy adults with inherited TNF deficiency","volume":"633","author":"Arias","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.09.002_bb0310","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/febs.13771","article-title":"Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease","volume":"283","author":"Blander","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.it.2025.09.002_bb0315","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4049\/jimmunol.2200686","article-title":"IFN receptor 2 regulates TNF-alpha-mediated damaging inflammation during Aspergillus pulmonary infection","volume":"213","author":"Rynda-Apple","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0325","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000506931","article-title":"Oropharyngeal candidiasis as a presenting symptom of Crohn's disease","volume":"14","author":"Sharif","year":"2020","journal-title":"Case Rep. Gastroenterol."},{"key":"10.1016\/j.it.2025.09.002_bb0330","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.3748\/wjg.v22.i25.5655","article-title":"Oral pathology in inflammatory bowel disease","volume":"22","author":"Muhvic-Urek","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.it.2025.09.002_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0340","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","article-title":"Interferon-lambda orchestrates innate and adaptive mucosal immune responses","volume":"19","author":"Ye","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.09.002_bb0345","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.it.2025.09.002_bb0350","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:10:38Z","timestamp":1772125838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1471490625002212"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.09.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing IL-17\u2013mediated protection and IFN-\u03b3\u2013driven pathology at mucocutaneous barriers","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}